Objectives: Children undergoing cardiopulmonary bypass develop clinically impactful capillary leak of unclear etiology. A widely held hypothesis that exposure of circulating cells to the cardiopulmonary bypass circuit induces the release of inflammatory mediators that act to disrupt intercellular junctions of capillary endothelial cells inducing paracellular capillary leak either directly or through new gene expression. Design: Cohort study. Setting: Tertiary pediatric hospital. Patients: Twenty children undergoing surgery with cardiopulmonary bypass for congenital heart disease. Serum was collected before cardiopulmonary bypass, 2 hours after cardiopulmonary bypass, and 18 hours after cardiopulmonary bypass. Interventions: None. Measurements and Main Results: We analyzed the effects of 10% patient sera on the "function, structure, and gene expression" of cultured human dermal and pulmonary microvascular endothelial cells. Changes in barrier "function" were measured using transendothelial electrical resistance. Associations between changes in transendothelial electrical resistance and subject characteristics were analyzed using linear mixed effects model with area under the resistance curve as outcome. Changes in junctional "structure" were assessed by analyzing the organization of the endothelial cell junctional proteins claudin-5 and VE-cadherin using immunofluorescence microscopy. Changes in inflammatory "gene expression" were measured using real-time quantitative reverse transcription-polymerase chain reaction. All serum samples induced a transient, 120-minute increase in transendothelial electrical resistance followed by persistent loss of barrier function. Unexpectedly, sera collected postcardiopulmonary bypassinduced significantly less loss of barrier function in both dermal and pulmonary capillary endothelial cell compared with precardiopulmonary bypass sera. Consistent with the transendothelial electrical resistance results, claudin-5 and vascular endothelialcadherin junctional staining showed less disruption in cultures treated with postcardiopulmonary bypass sera. Expression of genes commonly associated with inflammation was largely unaffected by patient sera. Conclusions: Contrary to the hypothesis, sera taken from children after cardiopulmonary bypass induces less capillary barrier disruption relative to sera taken from children before cardiopulmonary bypass, and none of the sera induced significant changes in expression of inflammatory genes. (Pediatr Crit Care Med 2018; 19:609-618) Key Words: capillary leak; cardiopulmonary bypass, endothelial activation, endothelial dysfunction, pediatric critical care, transendothelial electrical resistance C hildren who are exposed to cardiopulmonary bypass (CPB) during surgical repair or palliation of congenital heart disease develop postoperative capillary leak, leading to intravascular volume depletion in the setting of total body fluid overload (1). Such fluid shifts complicate postoperative fluid, diuretic and inotropic support management. These clinical effects are thought to be mediated by changes
in endothelial cell (EC) "barrier function, structure, and gene expression"; however, the specific inciting factors due to CPB are unknown (2) . A widely held general explanation is that exposure of the patient's circulating blood cells to the artificial surfaces of the bypass circuit, combined with parenchymal ischemia-reperfusion injury, induces a systemic inflammatory response that includes release of variety of soluble mediators in serum (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Some of the identified mediators, such as angiopoietin-2 and tumor necrosis factor (TNF), are known to act on cultured ECs to destabilize barriers, directly and via new gene expression (dependent upon the transcription factor nuclear factor [NF]-κB) (15, 16) . Such studies have not been particularly revealing of pathologic changes in EC associated with post-CPB leak. Other, yet unidentified mediators with barrier stabilizing effects may be released into the circulation by CPB and may have an effect on ECs. An alternative possibility is that the soluble mediators released into serum after CPB do not play a significant role in the initiation or propagation of capillary leak. There is a significant knowledge gap between the levels of such mediators in serum and their cumulative effect on ECs and contribution of capillary leak (17) . A better understanding of postoperative capillary leak may guide therapies (i.e., fluids, diuretic, or inotropes) and foster the development of new therapies that target the endothelium.
Our hypothesis is that capillary leak is caused by EC changes induced by the cumulative effect of cytokines and other mediators that are released into the circulation following exposure to CPB. To test this, we treated cultured human dermal microvascular ECs (HDMECs) and human pulmonary microvascular ECs (HPMECs) with sera collected from children undergoing CPB who were enrolled in a prior study. We specifically investigated changes in EC "barrier function, structure, and gene expression." We used a culture model of the capillary endothelium, as different vascular segments (i.e., arteriole, capillary, venule) respond to stimulation differently and result in variable clinical effects (18) . Specifically, postconfluent HDMEC and HPMEC form claudin-5-dependent tight junctions and do not depend on adherens junctions that are characteristic of venular ECs (19) . We anticipated that serum collected after CPB would induce a decrease in "barrier function" that would correlate with disassembly of EC "junctional structure" and increased inflammatory "gene expression" in HDMEC and HPMEC monolayers compared with sera from before CPB.
MATERIALS AND METHODS
We analyzed serum samples from a prior observational study that was conducted at Yale New Haven Children's Hospital from October 2013 to August 2014 (20) . In that study, we included 20 children age 2 months to 17 years old who underwent elective repair or palliation of their congenital heart disease under CPB. Three blood samples were obtained from each study participant. First was after catheter placement (T1, after anesthesia induction, before surgery); second was 2 hours after surgery (T2, after chest closure and modified ultrafiltration [MUF] , on arrival to the PICU); and third was 18 hours after surgery (T3). Samples were collected in standard red-top tubes with no anticoagulants, and sera was isolated by removal of clotted blood. The samples were stored at -80°C per Yale University biological repository guidelines and had undergone a single freeze-thaw cycle prior to use in the current study. Because all samples had been previously obtained, the Human Investigations Committee at Yale University approved this study with a waiver of consent.
At our institution, CPB circuit is pump primed with heparin, methylprednisolone, and aminocaproic acid. In patients weighing less than 10 kg, the circuit is additionally primed with RBCs and fresh frozen plasma. All patients underwent 10 minutes of MUF at the end of the surgery using a Hemocor HPH hemoconcentrator (Minntech Corporation, Minneapolis, MN). Patient baseline demographics, length of PICU stay, Inotropic Score, total bypass time, aortic cross clamp time, and duration of mechanical ventilation were provided in a deidentified database.
Laboratory Methods
Cell Isolation and Culture. HDMEC and HPMEC cultures used in this study were both isolated and cultured as previously described from deidentified and discarded human surgical specimens from Yale Department of Pathology. Their generation and use have been classified as Not Human Research by the Yale Human Investigation Committee (20, 21) . Sources of surgical specimens include both males and females. Briefly, HDMECs were isolated by dermatome harvest of the superficial most 0.5-0.7 mm of skin, followed by enzymatic digestion (Dispase, 50 U/ mL; BD Biosciences, San Jose, CA) at 37°C and culture on 10 μg/ mL human plasma fibronectin-coated (Millipore, Burlington, MA) tissue culture plastic (BD Biosciences) in endothelia growth medium 2-microvascular growth medium with 10% fetal bovine serum (Lonza, Basel, Switzerland). HPMECs were isolated by enzymatic digestion from anatomically normal regions of discarded lung resection surgical specimens and then cultured under the same conditions as HDMECs. Primary colonies were suspended and then immunoselected for CD31 expression using commercially available magnetic bead (Miltenyi Biotec, San Diego, CA). After selection, cells were serially passaged by trypsin resuspension onto 0.1% gelatin-coated (Sigma-Aldrich, St. Louis, MO) tissue culture plastic (Falcon/Corning, Corning, NY). Both HDMECs and HPMECs were assayed 24-36 hours post visual confluence, at which time transendothelial electrical resistance (TEER) levels plateau, indicative of formation of tight junctions. For HDMECs cultures acclimated to human serum, cultures were thawed in media containing 50% human, 50% bovine serum for 24 hours, then tested as described below in growth media made with 100% human serum (Sigma-Aldrich, H4522) instead of fetal bovine serum.
Assessment of Barrier Function. TEER of endothelial monolayers was assessed by electrical cell-substrate impedance sensing (Applied Biophysics, Troy, NY), using a 4 by 96-well reading system that allows quadruplicate replicates across all cell types to provide a real-time, noninvasive, label-free, and quantitative measure of endothelial barrier function (22) . HDMECs or HPMECs were placed on gelatin-coated 96-well gold electrode arrays (catalog number 96W20idf; Applied Biophysics), and TEER measurements were obtained daily over 3-5 days to monitor increasing barrier integrity until the monolayers reached a plateau that coincided with maturation of tight junctions. The TEER at the start of the experiment is referred to as "the basal TEER level," and subsequent measurements are divided by the basal value to produce normalized TEER values. Normalization facilitates comparisons among experiments and cell types. HDMEC and HPMEC monolayer resistances were measured as previously described (22) with the addition of 10% patient serum or an equal volume of phosphate buffered saline (PBS) (Sigma-Aldrich, negative control) or 1.0 ng/mL TNF in PBS (positive control). We used 10% serum as that is a standard additive to cell culture media, tolerated well by EC cultures and would provide sufficient amount of cytokine for detection of effect by TEER. Data were collected over 24 hours. To investigate the effects of higher patient serum concentrations, we added either 30% or 50% sera from four patients to HDMECs acclimated to human serum-based media and observed TEER changes.
Assessment of Junctional Structure. For confocal immunofluorescence microscopy analysis, confluent HDMECs and HPMECs monolayers, grown on gelatin-coated glass cover slips, were exposed to PBS or 10% patient serum for 6 hours, washed with PBS, and fixed in 95% ethanol for 30 minutes at 4°C (23) . For two color immunofluorescence imaging, monolayers were incubated overnight in mouse anticlaudin-5 antibody (Invitrogen number 35-2,500) or rabbit antihuman VE-cadherin antibody (Invitrogen number PA5-19612), diluted in TBS/0.2% triton-X-100/5% normal donkey serum. Alexa488 Donkey antimouse and antirabbit secondary antibodies (Invitrogen [Carlsbad, CA] number 35-2,500) or rabbit antihuman vascular endothelial (VE)-cadherin antibody (Invitrogen number PA5-19612), diluted in tri-buffered saline/0.2% triton-X-100/5% normal donkey serum. Alexa488 Donkey antimouse and antirabbit secondary antibodies (Invitrogen number A-21202, A-10040) were used to detect primary antibody, and glass coverslips were mounted for immunofluorescence analysis in ProLong mounting media (Invitrogen). Randomly selected (minimum of five images per experimental condition) fluorescence photomicrographs were collected using a Zeiss Axiovert fluorescence microscope and Plan-APOCHROMAT, 63× oil objective (Zeiss, Oberkochen, Germany) with a Hamamatsu ORCA-ER digital camera (Hamamatsu Photonics, Bridgewater, NJ). Quantification of nonadjacent cellular circumference and confluent claudin-5 junctional staining was determined with the tracing tool in ImageJ (v1.51p; National Institutes of Health, Bethesda, MD) for 20 randomly selected cells in each condition. Due to limited patient-derived serum samples, confocal experiments were run on four sets of patient samples. Patients were selected based on availability of serum and closeness of fit to the pooled average TEER curve.
Assessment of Gene Expression. Real-time quantitative reverse transcriptase polymerase chain reaction (PCR) analysis was conducted on messenger RNA isolated from HDMECs or HPMECs using an RNeasy Mini kit (Qiagen, Redwood City, CA), per the manufacturer's protocol. Cells were treated with 10% PBS as a negative control and 10 ng/mL of TNF as a positive control. Samples were collected in duplicate after 4 hours of exposure to sera. The high-capacity complementary DNA reverse transcription kit (Applied Biosystems, Foster City, CA) was used to synthesize cDNA from RNA. All PCR reactions were assembled with TaqMan gene expression master mix and manufacturer-validated TaqMan gene expression probes (Applied Biosystems number Hs02786624_g1, Hs00900055_ m1, Hs00169867_m1, Hs01065279_m1, Hs01574665_m1, Hs00174131_m1 and Hs00174057_m1). Reactions were analyzed on a CFX96 real-time system using CFX Manager software (BioRad Laboratories, Hercules, CA). Gene expression levels were normalized to glyceraldehyde 3-phosphate dehydrogenase. Cells were treated for 4 hours with 10% PBStreated cells as a negative control and 10 ng/mL of TNF (R&D Systems, Minneapolis, MN) as a positive control. Differential gene expression was normalized to PBS-treated control group. Due to limited patient-derived serum samples, gene expression experiments were run on four sets of patient samples. Patients were selected based on availability of serum and closeness of surgical and clinical course to the cohort averages ( Table 1) .
Statistical Methods
The association between the primary outcome of area under the TEER curves and time and type of cells were analyzed using a linear mixed effects model using Stata 15.1 (StataCorp LLC, College Station, TX). The association was adjusted for age and bypass time. Age, bypass time, and the interaction between time and type of cells were not statistically significant and were thus dropped from the model. The final model had time and type of cells as dependent variables.
Gene expression data are expressed as mean and sd. Unpaired t tests were used to make statistical comparisons between treatment conditions. Comparisons between multiple treatment conditions were performed using one-way analysis of variance with a Tukey test for post hoc analysis. Statistical analyses were performed using GraphPad Prism software (v7.01; Graphpad, La Jolla, CA). In all experiments, p value of less than 0.01 was considered statistically significant.
RESULTS

Patients Characteristics
We analyzed sera from 20 pediatric patients (10 boys and 10 girls) who had undergone CPB for congenital heart disease repair or palliation (Table 1) . Median (interquartile range) age was 31 months (4.5-152 mo), and 40% were less than 1 year old. The median CPB time was 68 minutes (54-101 min), and the median cross clamp time was 33 minutes (23-38 min) . No patients required repeat operations within 30 days. The median 24-hour fluid balance was positive 27 mL/kg (12-63 mL/kg), and patients received invasive mechanical ventilation for a median of 5 hours (2-17 hr). All patients were discharged alive from the hospital. There were no late complications such as infections, postpericardiotomy syndrome, or readmissions. 
Barrier Function
All serum samples induced a transient 15% increase in TEER over 2 hours followed by a sustained decrease in barrier function compared with pretreatment levels (Fig. 1, A and B) .
Unexpectedly, sera collected after patient exposure to the CPB circuit (both T2 and T3) consistently caused a lesser decline in TEER compared with sera collected just prior to surgery and CPB (T1) in both HDMECs and HPMECs. This difference was significant for serum collection time points in both cell types, although HPMECs were more responsive to serum-induced changes. Area under the curve analysis revealed 9.4, 10.3, and 10.4 for HDMEC and 10.8, 11.3, and 11.6 for HPMEC treated with T1, T2, and T3, respectively (Supplementary Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/PCC/A645; legend, Supplemental Digital Content 3, http://links.lww.com/ PCC/A647). Increasing the concentration of patient serum did not change the magnitude or pattern of TEER changes in HDMEC (Supplementary Fig. 2 , Supplemental Digital Content 2, http://links.lww.com/PCC/A646; legend, Supplemental Digital Content 3, http://links.lww.com/PCC/A647). We did not identify any patterns of TEER loss or gain in relationship to any clinical variables for individual TEER curves.
To detect the presence of inhibitors to compounds that may induce NF-κB-mediated permeability, we screened patient sera on HDMEC. Given that we lacked sufficient sera to test all 20 patients, we assessed the effects of sera from three of the patients on the HDMEC TEER response induced by 1 ng/mL of TNF (Fig. 1C) . We chose a submaximal effect concentration of TNF for these experiments to increase chances that we could detect inhibition, additivity, or synergy of effects with patient sera. When combined with patient sera, the addition of TNF resulted in approximately 10% less decrease in leak compared with the capillary leakinduced TNF alone.
EC Junctional Structure
Confocal microscopy revealed differences in tight junction protein claudin-5 and adherens junction protein VEcadherin staining in both HDMECs ( Fig. 2A, quantification  Fig. 2B ) and HPMECs (Fig. 3A, quantification Fig. 3B ). Only T2 sera was used for postbypass comparison due to limited availability of patient samples and similarity of TEER curves between T2 and T3 sera. Staining for the tight-junctional protein claudin-5 was qualitatively darker in HDMEC and HPMEC treated with post-CPB sera (T2) compared with pre-CPB sera. Staining for the adherins-junction protein VE-cadherin demonstrated less disruption in HDMEC and HPMEC treated with post-CPB sera compared with pre-CPB sera. This observation is quantified by measuring linearly confluent staining divided by the total cell circumference. PBS-treated cells demonstrated more continuous staining of claudin-5 (96% ± 3.3% for HDMEC and 82% ± 11% in HPMEC) than cells treated with T1 (58% ± 18%; p < 0.001 and 39% ± 15%; p < 0.001, respectively) and T2 (76% ± 9%; p = 0.004 and 69% ± 13%; p = not significant) sera. For VEcadherin, the staining pattern was less disrupted with more continuous staining evident in all conditions (90% ± 8%, 79% ± 12%; p = 0.031 and 86% ± 7%; p = not significant for HDMECs treated with PBS, T1, and T2 sera compared with 89% ± 7%, 80% ± 10%, p = 0.045, and 81% ± 10%; p = not significant for HPMEC, respectively). Overall, the staining pattern for HDMECs and HPMECs revealed similar patterns of junctional disruptions (Fig. 2) .
EC Gene Expression
Transcriptional changes in HDMECs (Fig. 4) and HPMECs ( Fig. 5) were analyzed after exposure to pre-and postbypass serum. Overall, there were no significant differences in transcript levels for any of the measured inflammatory genes induced among the responses to T1 versus T2 versus T3 sera. Treatment of EC with 10 ng/mL TNF (positive control) resulted in significant increases in transcript levels of E-selectin and interleukin-6 as well as angiopoietin-2 in HDMEC and vascular-endothelial growth factor in HPMEC compared with cells treated with PBS (negative control).
DISCUSSION
The results of this study suggest that sera from pediatric patients after CPB period do not contain stable mediators that induce barrier disruption or inflammatory gene expression on cultured human microvascular ECs compared with preprocedure control samples from the same patients. Although there was evidence of barrier disruption across all time points, post-CPB sera (T2 and T3) induced less barrier disruption in cultured human microvascular ECs than sera obtained prior to bypass (T1). These results are unlikely to be due to dosage We chose to use HDMECs and HPMECs in these experiments because, unlike more widely studied human umbilical vein ECs (HUVECs), HDMECs and HPMECs replicate the capillary vascular segment. Specifically, HDMECs and HPMECs form claudin-5-dependent tight junctions and more accurately reflect the physiology of the capillary vascular segment (16) . HUVEC junctions are characterized primarily by adherens junctions that depend on VE-cadherin and are sensitive to extracellular calcium levels. HUVECs cannot provide information on capillary endothelial permeability involving tight junction breakdown like HDMECs or HPMECs (20) . Therefore, our Pediatric Critical Care Medicine www.pccmjournal.org 615 study may be a more accurate in vitro investigation of the effects of CPB on capillary ECs. This distinction may explain the difference between our results and previous investigations that demonstrate an increase in permeability (7) and apoptosis (25) when HUVECs are treated with post-CPB samples. Our findings of minimal changes in capillary permeability are consistent with human observations that changes in lung mechanics after CPB may not be attributable to pulmonary capillary vascular permeability changes (9, 26) .
A possible explanation for our findings would be the release of compounds that act as inhibitors to proinflammatory cytokines such as TNF, as has been observed in septic patients (27) . If such compounds were released by CPB, the effects of barrier destabilizing compounds in serum (like TNF) may not be detected by TEER changes. To determine if the post-CPB sera used in our study contained inhibitors of inflammation that could mask an effect, we combined these sera with TNF. We observe characteristic breakdown of capillary tight junctions with TNF stimulation alone, and the effects of patient sera augmented with 1 ng/mL TNF appear roughly additive of the two treatments with no evidence that pre-or post-CPB sera either neutralize or synergize with TNF actions. The observed changes seemed to reflect the persistent addition of the initial increase in barrier that all the CPB patients sera induce rather than effective neutralization. Interestingly, the smallest reduction in the cytokine response was caused by prebypass sera.
Our study focused on the functional effects of patient sera rather than the individual cytokines or mediators present pre or post CPB. Our results suggest investigating other factors may instigate or propagate capillary leak. Such considerations include patient factors (i.e., cooling-rewarming or total fluid administered), short-lived factors in the vascular compartment (i.e., proteases or coagulation proteins). Alternatively, patient sera could act on other cell types to produce contact-dependent or paracrine signals that cause EC responses and therefore not detected when using pure EC cultures. Although previous studies have shown increase in cytokine levels post CPB (28), our analysis of HDMEC and HPMEC did not reveal transcriptional differences induced by pre-or post-CPBN sera. These data suggest that systemically detected cytokines may not be produced by capillary ECs stimulated by long-lived systemic signaling mediators post CPB or that such cytokines may originate predominately from other cell types.
Two additional factors complicate the interpretation of our results. There is no generally accepted definition or diagnostic criteria for capillary leak (29) , and our cohort generally did very well with minimal requirements for ventilatory and inotropic support. Our findings may not be generalizable to sicker patients, and serum from such patients may produce different TEER changes. However, these patients represent a common postcardiac population that is often thought to be affected by capillary leak. A set of standardized and generally accepted clinical criteria to diagnose capillary leak and score its severity would allow more precise comparisons for future investigations into capillary leak.
Our study, which challenges a widely held assumption about the causes of capillary leak following CPB, has several additional limitations. Although the simplest interpretation of these data is that CPB does not induce release of soluble mediators that cause capillary leak, sera differ from whole blood in significant ways, such as absence of blood cells (platelets, leukocytes), presence of active coagulation cascade components, or the presence of short-lived or protease-sensitive vasoactive Figure 4 . Changes in messenger RNA levels for proinflammatory transcripts in human dermal microvascular endothelial cells (HDMECs) treated with 10% patient serum for 4 hr. Serum from pre cardiopulmonary bypass (CPB) (T1), post-CPB (T2), and 18 hr after CPB (T3) were assessed with saline treated (negative control) and tumor necrosis factor (TNF) treated (positive control). E-selectin, interleukin (IL)-6 (both markers of nuclear factor-κB mediated endothelial activation), and angiopoietin (Angpt)-2 expression were significantly different between control groups and patient samples (A-C), whereas vascular-endothelial growth factor (VEGF) expression was not significantly changed. D, Most importantly, no significant differences were observed among T1, T2, or T3 sera. Compilation of three different patient sera experiments run in duplicate, p values indicated.
mediators. Nevertheless, our findings seem to go against the commonly held beliefs about the systemic dissemination of mediators that induce capillary leak and may help to guide future research on capillary leak. Furthermore, we analyzed a relatively small sample size of 20. We chose this number because we leveraged samples from a previous study that had observed an effect. Furthermore, samples from newly enrolled patients are unlikely to be comparable with the original cohort because there have been changes in the practice of CPB in our institution since the original study was completed. We also have limited data related to immune modulators administered perioperatively, such as specific dosing of corticosteroids or anti-inflammatories. We recognize that this may limit the interpretation of capillary leak in this population. Each sample had experienced a freeze-thaw cycle; however, our screen was aimed to detect the net effects of stable long-lived mediators of capillary leak. Last, we lacked sufficient sample volume to assay the sera for specific cytokines.
CONCLUSIONS
We demonstrate that sera collected from patients after CPB had less destabilizing effects on human capillary endothelial barrier function and junctions compared with pre-CPB samples and may not induce proinflammatory gene expression. A standardized definition of capillary leak would help to guide future studies that may consider alternative explanations for post-CPB capillary leak.
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